e-learning
resources
Glasgow 2004
Monday 06.09.2004
Pathophysiology of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension
E. Marcos, E. Fadel, O. Sanchez, M. Humbert, P. Dartevelle, G. Simonneau, S. Adnot, S. Eddahibi (Creteil, Clamart, Le Plessis Robinson, France)
Source:
Annual Congress 2004 - Pathophysiology of pulmonary hypertension
Session:
Pathophysiology of pulmonary hypertension
Session type:
Oral Presentation
Number:
2695
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Marcos, E. Fadel, O. Sanchez, M. Humbert, P. Dartevelle, G. Simonneau, S. Adnot, S. Eddahibi (Creteil, Clamart, Le Plessis Robinson, France). Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Eur Respir J 2004; 24: Suppl. 48, 2695
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Role of endothelial and smooth muscle cells in vascular wall remodeling of large pulmonary arteries in patients with CTEPH
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007
Increased p130
Cas
activity induces smooth muscle cell proliferation and migration in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
CCR2/CCR5-mediated macrophage–smooth muscle cell crosstalk in pulmonary hypertension
Source: Eur Respir J, 54 (4) 1802308; 10.1183/13993003.02308-2018
Year: 2019
Hyperplasia of pulmonary artery smooth muscle cells in primary and secondary pulmonary hypertension is causally related to serotonin transporter overexpression
Source: Eur Respir J 2002; 20: Suppl. 38, 5s
Year: 2002
IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats
Source: Eur Respir J 2011; 37: 1104-1118
Year: 2011
Dexamethasone induces anti-remodelling effects in rat pulmonary arterial smooth muscle cells
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
Vascular remodeling in chronic thromboembolic pulmonary hypertension: Involvement of dedifferentiated smooth muscle cells and C-reactive protein
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension
Source: Eur Respir J 2007; 29: 937-943
Year: 2007
Contribution of angiopoietin/Tie2 pathway to pulmonary artery smooth muscle hyperplasia in idiopathic pulmonary hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
Involvement of pulmonary artery smooth muscle cell apoptosis in simvastatin-induced regression of hypoxic pulmonary hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
Hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: possible mechanisms
Source: Eur Respir J 2004; 24: Suppl. 48, 561s
Year: 2004
miR-424 and muscle wasting in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Caspase-1 triggers smooth muscle cell proliferation in hypoxic pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
Shroom expression is attenuated in pulmonary arterial hypertension
Source: Eur Respir J 2008; 32: 871-880
Year: 2008
Increased expression of endothelin
B
receptors in the pulmonary arterial smooth muscle cells of fawn-hooded rat
Source: Eur Respir J 2001; 18: Suppl. 33, 416s
Year: 2001
Pathophysiology of bronchial smooth muscle remodelling in asthma
Source: Eur Respir J 2010; 36: 1174-1184
Year: 2010
Vascular smooth muscle cell phenotypes in primary pulmonary hypertension
Source: Eur Respir J 2001; 17: 316-320
Year: 2001
Mir-17 modulates smooth muscle cell markers, apoptosis and BMPR-II levels in human pulmonary artery smooth muscle cells
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept